Periodic Reporting for period 1 - CC-CHARGED (Strongly Polarized Carbon: Taming Fundamental Intermediates and Their Applications)
Période du rapport: 2023-04-01 au 2025-09-30
Importantly, we have developed new routes to unsaturated diazo compounds using azides or nitrous oxide as diazo transfer reagents. We have shown that the products (diazoalkenes) undergo exchange reactions in which dinitrogen can be exchanged with CO, isocyanides or carbenes.
Two milestones of the ERC project were the synthesis of reagents allowing C(sp2) atom transfer (Ph3PCN2; Science 2024, 385, 305) and C(sp3) atom transfer (Ph2SCN2; Science 2025, 387, 885). A short synthetic route using N2O as the diazo transfer reagent was developed and the electronic structure and reactivity of the reagents were analyzed in detail. These reagents allow new disconnections in organic synthesis (carbonyl to alkynes or 1,3-butatrienes) and allow the creation of 3D structures containing spiropentane fragments including rigid tricyclic cores. The generalization of the fragment transfer concept (C atom or CN2) is part of the ongoing work in the group.
Furthermore, the new diazo compounds provided direct access to novel paramagnetic compounds that could be characterized by EPR and ENDOR spectroscopy at low temperatures. We were able to show that monosubstituted carbon diradicals such as Ph3P→C represent a unique class of compounds that can be considered as an adduct of carbon in its electronic ground state (3P) and a neutral ligand (PPh3). Current work is aimed at increasing the stability and investigating applications of such fundamental compounds in organic synthesis.
CC-CHARGED has pioneered C-atom transfer reagents. The reagents developed to introduce C-atoms appear highly attractive for a broad organic market, while the products of 3D carbon atom transfer, tricyclic rigid compounds, appear highly interesting as novel bioisosters in areas related to medical research. We have filed a patent application on the work described in Science 2025, 387, 885 with a perspective to developing commercial solutions. Further research in this area is needed to investigate the stability, scope and scalability of the reagents, paving the way for a rich chemistry of tricyclic molecules including applications in drug design.